AI-generated summary
The authors studied whether photobiomodulation therapy at three energy doses (15, 30, and 60 J per site) affected physiological and performance measures in 15 male recreational runners during submaximal and maximal running tests. In this randomized, double-blind, placebo-controlled crossover trial, the authors report improvements in several measures with each dose, and that the 30 J dose appeared to produce more beneficial effects than 15 or 60 J.
- Participants
- 15
- Who or what was studied
- Fifteen male recreational runners
- Limits stated in the abstract
- The study involved a small sample of 15 recreational runners, and the abstract does not state the wavelengths used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Total energy
- 60 J, 30 J, 15 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Dose, Light-emitting diode, Placebo-controlled. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.